[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intramuscularly administer 2 doses of 0.5 mL at an interval of 28 days. In addition; a dose of 0.5 mL is administered intramuscularly at 13 weeks after the second dose.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 703, "treatment_name": "Kd-414", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intramuscularly administer 2 doses of 0.5 mL at an interval of 28 days. In addition; a dose of 0.5 mL is administered intramuscularly at 13 or 26 weeks after the second dose.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "2;days0-28;IM", "treatment_id": 703, "treatment_name": "Kd-414", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": " booster 13 weeks after the second dose", "treatment_id": 703, "treatment_name": "Kd-414", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": " booster 26 weeks after the second dose", "treatment_id": 703, "treatment_name": "Kd-414", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]